Hinge Health, Inc. 8-K
Research Summary
AI-generated summary
Hinge Health, Inc. Reports 2026 Annual Meeting Results
What Happened
Hinge Health, Inc. (HNGE) filed an 8‑K on June 4, 2026 reporting the results of its June 3, 2026 Annual Meeting of Stockholders. Shareholders elected Teddie Wardi and Tyler Sloat as Class I directors to serve until the 2029 annual meeting, and ratified Deloitte & Touche LLP as the company’s independent registered public accounting firm for the year ending December 31, 2026. The record date for voting was April 10, 2026; Class A shares had one vote each, Class B shares had 15 votes each, and Series E preferred shares voted based on convertible shares (Series E did not vote on the director election).
Key Details
- Director elections (Class I, term through 2029):
- Teddie Wardi — For: 276,921,911; Withheld: 14,888,631; Broker non‑votes: 14,168,983.
- Tyler Sloat — For: 291,330,022; Withheld: 480,520; Broker non‑votes: 14,168,983.
- Auditor ratification: Deloitte & Touche LLP — For: 305,789,374; Against: 121,058; Abstentions: 69,093; no broker non‑votes.
- Filing signed by CFO James Budge and submitted as Form 8‑K on June 4, 2026.
Why It Matters
The meeting confirmed the company’s board composition for the next multi-year term and ensured continuity in external audit oversight by ratifying Deloitte. These votes are routine governance matters but are material for shareholders because they affect board control and the choice of external auditor, both of which influence oversight of financial reporting and corporate strategy.
Loading document...